JHJuyeon Hwang

Juyeon Hwang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juyeon Hwang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development of K-CORE: a web-based platform for integrated clinico-genomic analysis.

    by Juyeon Hwang, Jae Woo Ahn, Jae Wook Lee, So-Youn Jung, Eun-Gyeong Lee, Heejung Chae, Harim Koo, Hyosoung Cha, Junetae Kim, Kwangmin Kim, et al.

    One of the key challenges in cancer treatment and precision oncology is the use of multi-omics data and their integration into matched clinical information. Although several analytical portals have been developed, most platforms do not support user-uploaded data or the integrated analysis of clinical and multi-omics datasets. To address these limitations, we developed the Korea Cancer Omics Research (K-CORE) portal, a user-friendly analytical platform designed to integrate and analyze multi-omics and clinical data. K-CORE supports various omics levels and a wide range of analytical tools. To validate the utility and reproducibility of the K-CORE, we designed synthetic datasets that reflected real-world omics data distributions. The analytical results from K-CORE were compared side by side with those from widely used R packages such as maftools and edgeR. In conclusion, K-CORE offers a practical and intuitive platform for the multidomain integration of clinical and omics data, supporting the advancement of precision oncology. Nevertheless, as analytical technologies and precision oncology continue to evolve, continuous maintenance and user feedback will become essential for future platform improvements.

  • Open Access

    Application of a Natural Language Processing Framework for Data Extraction From Pathology Reports Across Multiple Cancer Types

    by Phillip Park, Yeonho Choi, Nayoung Han, Soobin Park, Ye-Lin Park, Juyeon Hwang, Kui Son Choi, Chong Woo Yoo, Hyun-Jin Kim

    Park P, et al. J Korean Med Sci. 2026 Feb;41:e79. https://doi.org/10.3346/jkms.2026.41.e79


  • Open Access

    Mortality Prediction Modeling for Patients with Breast Cancer Based on Explainable Machine Learning

    by Sang Won Park, Ye-Lin Park, Eun-Gyeong Lee, Heejung Chae, Phillip Park, Dong-Woo Choi, Yeon Ho Choi, Juyeon Hwang, Seohyun Ahn, Keunkyun Kim, et al.

    Background/Objectives: Breast cancer is the most common cancer in women worldwide, requiring strategic efforts to reduce its mortality. This study aimed to develop a predictive classification model for breast cancer mortality using real-world data, including various clinical features. Methods: A total of 11,286 patients with breast cancer from the National Cancer Center were included in this study. The mortality rate of the total sample was approximately 6.2%. Propensity score matching was used to reduce bias. Several machine learning models, including extreme gradient boosting, were applied to 31 clinical features. To enhance model interpretability, we used the SHapley Additive exPlanations method. ML analyses were also performed on the samples, excluding patients who developed other cancers after breast cancer. Results: Among the ML models, the XGB model exhibited the highest discriminatory power, with an area under the curve of 0.8722 and a specificity of 0.9472. Key predictors of the mortality classification model included occurrence in other organs, age at diagnosis, N stage, T stage, curative radiation treatment, and Ki-67(%). Even after excluding patients who developed other cancers after breast cancer, the XGB model remained the best-performing, with an AUC of 0.8518 and a specificity of 0.9766. Additionally, the top predictors from SHAP were similar to the results for the overall sample. Conclusions: Our models provided excellent predictions of breast cancer mortality using real-world data from South Korea. Explainable artificial intelligence, such as SHAP, validated the clinical applicability and interpretability of these models.